Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …

Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial,
venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or …

The objective was to develop evidence-based recommendations for the management of
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …

The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis;
pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental …

The antiphospholipid syndrome is an autoimmune disorder of hypercoagulability
characterized by the presence of autoantibodies to various phospholipids or phospholipid …

The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or
pregnancy morbidity in combination with the persistent presence of circulating …

Background A range of treatments have been proposed to improve pregnancy outcome in
recurrent pregnancy loss associated with antiphospholipid antibody (APL). Small studies …

ContextAntiphospholipid antibodies are autoantibodies directed against proteins that bind to
phospholipid. Antiphospholipid antibody syndrome (APS) refers to the association between …

Objective. To compare live birth rates in women with recurrent pregnancy loss (RPL) and
either autoantibodies or a coagulation abnormality, treated with low molecular weight …

Objective To determine the efficacy of a daily dose of 81 mg aspirin in primary thrombosis
prevention in asymptomatic, persistently antiphospholipid antibody (aPL)–positive …